TY - JOUR
T1 - Effect of norepinephrine on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets
AU - Sorenson, R. L.
AU - Elde, R. P.
AU - Seybold, V.
PY - 1979
Y1 - 1979
N2 - The rate of insulin, glucagon, and somatostatin secretion was measured from isolated rat islets maintained in a perifusion system. The effect of norepinephrine (NE) was simultaneously determined on the release rate of all three hormones. Norepinephrine was employed at an acute dose of 10 μM and in graded doses from 1 nM to 10 μM in the presence of high (22 mM) and low (1.4 mM) glucose concentrations. Under both high and low glucose conditions, insulin secretion was maximally inhibited at 10 μM NE concentration and was significantly depressed at 100 nM NE concentration. Under both high and low glucose conditions, glucagon release was maximally stimulated at 10 μM NE concentration and was significantly elevated at 10 nM NE concentration. Under high and low glucose conditions, somatostatin release was inhibited by 10 μM NE concentration and was significantly depressed at 100 nM NE concentration. During the initial maximal stimulation of glucagon, NE inhibition of somatostatin and insulin was prevented, possibly by the high level of glucagon released. A paracrine effect of glucagon on beta and delta cells is proposed.
AB - The rate of insulin, glucagon, and somatostatin secretion was measured from isolated rat islets maintained in a perifusion system. The effect of norepinephrine (NE) was simultaneously determined on the release rate of all three hormones. Norepinephrine was employed at an acute dose of 10 μM and in graded doses from 1 nM to 10 μM in the presence of high (22 mM) and low (1.4 mM) glucose concentrations. Under both high and low glucose conditions, insulin secretion was maximally inhibited at 10 μM NE concentration and was significantly depressed at 100 nM NE concentration. Under both high and low glucose conditions, glucagon release was maximally stimulated at 10 μM NE concentration and was significantly elevated at 10 nM NE concentration. Under high and low glucose conditions, somatostatin release was inhibited by 10 μM NE concentration and was significantly depressed at 100 nM NE concentration. During the initial maximal stimulation of glucagon, NE inhibition of somatostatin and insulin was prevented, possibly by the high level of glucagon released. A paracrine effect of glucagon on beta and delta cells is proposed.
UR - http://www.scopus.com/inward/record.url?scp=0018692168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018692168&partnerID=8YFLogxK
U2 - 10.2337/diab.28.10.899
DO - 10.2337/diab.28.10.899
M3 - Article
C2 - 383555
AN - SCOPUS:0018692168
SN - 0012-1797
VL - 28
SP - 899
EP - 904
JO - Diabetes
JF - Diabetes
IS - 10
ER -